Wire · opportunities
Could Electricity Zap Away Chronic Disease?
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 17 August 2026 · Fusion42 review
FDA approval of a novel bioelectronic nerve stimulator for rheumatoid arthritis demonstrates a new treatment modality that reduces inflammation via vagus nerve stimulation, with ongoing trials targeting other autoimmune diseases.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
Medtech founders developing chronic disease treatments face a sudden shift from drugs to targeted nerve stimulation devices. You can now explore new development paths that sidestep traditional drug risks and open faster regulatory routes.
◆ Coverage
1 source · 17 Aug 2026
◆ Related on Wire
◆ Topics